Sherona Sirkisoon

551 total citations
16 papers, 439 citations indexed

About

Sherona Sirkisoon is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sherona Sirkisoon has authored 16 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sherona Sirkisoon's work include Hedgehog Signaling Pathway Studies (7 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Sherona Sirkisoon is often cited by papers focused on Hedgehog Signaling Pathway Studies (7 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Sherona Sirkisoon collaborates with scholars based in United States and China. Sherona Sirkisoon's co-authors include Hui‐Wen Lo, Richard L. Carpenter, Kounosuke Watabe, Tadas Rimkus, Waldemar Debinski, Fei Xing, Michael D. Chan, Dongqin Zhu, Guangxu Jin and Daniel Doheny and has published in prestigious journals such as Biochemistry, Cancer Research and Oncogene.

In The Last Decade

Sherona Sirkisoon

16 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherona Sirkisoon United States 10 286 193 109 72 54 16 439
Carlos R. Gil Del Alcazar United States 7 247 0.9× 205 1.1× 109 1.0× 80 1.1× 91 1.7× 9 440
Craig Harlos Canada 8 196 0.7× 99 0.5× 115 1.1× 81 1.1× 99 1.8× 14 381
Svetlana Miklikova Slovakia 12 202 0.7× 168 0.9× 117 1.1× 45 0.6× 24 0.4× 17 401
Patrick Grierson United States 14 271 0.9× 206 1.1× 85 0.8× 44 0.6× 59 1.1× 38 514
JulieAnn Rader United States 6 304 1.1× 259 1.3× 136 1.2× 165 2.3× 48 0.9× 8 542
Austin Y. Shull United States 12 333 1.2× 124 0.6× 132 1.2× 40 0.6× 54 1.0× 18 481
Feda H. Hamdan United States 16 326 1.1× 146 0.8× 103 0.9× 28 0.4× 33 0.6× 25 507
Cheri A. Pasch United States 11 166 0.6× 203 1.1× 125 1.1× 42 0.6× 39 0.7× 31 397
Paula Kroon Netherlands 6 271 0.9× 283 1.5× 125 1.1× 98 1.4× 94 1.7× 10 539
Ziao Lin United States 5 331 1.2× 178 0.9× 79 0.7× 95 1.3× 27 0.5× 9 445

Countries citing papers authored by Sherona Sirkisoon

Since Specialization
Citations

This map shows the geographic impact of Sherona Sirkisoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherona Sirkisoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherona Sirkisoon more than expected).

Fields of papers citing papers by Sherona Sirkisoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherona Sirkisoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherona Sirkisoon. The network helps show where Sherona Sirkisoon may publish in the future.

Co-authorship network of co-authors of Sherona Sirkisoon

This figure shows the co-authorship network connecting the top 25 collaborators of Sherona Sirkisoon. A scholar is included among the top collaborators of Sherona Sirkisoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherona Sirkisoon. Sherona Sirkisoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thomas, Alexandra, Nathaniel S. O’Connell, Carolyn J. Park, et al.. (2023). Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study. American Heart Journal. 267. 33–43. 2 indexed citations
2.
Sirkisoon, Sherona, Grace L. Wong, Daniel Doheny, et al.. (2022). Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases. Cancer Letters. 540. 215726–215726. 38 indexed citations
3.
Rimkus, Tadas, Dongqin Zhu, Richard L. Carpenter, et al.. (2022). NEDD4 degrades TUSC2 to promote glioblastoma progression. Cancer Letters. 531. 124–135. 9 indexed citations
4.
Doheny, Daniel, Sara G. Manore, Grace L. Wong, et al.. (2022). Abstract 2433: Targeting tGLI1 pharmacologically as a new therapeutic strategy for breast cancer brain metastases. Cancer Research. 82(12_Supplement). 2433–2433. 1 indexed citations
5.
6.
Wang, Guanwen, Juan Wang, Antao Chang, et al.. (2021). Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene. 40(12). 2335–2335. 7 indexed citations
7.
Doheny, Daniel, Sherona Sirkisoon, Richard L. Carpenter, et al.. (2020). Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene. 39(42). 6589–6605. 63 indexed citations
8.
Wang, Guanwen, Juan Wang, Antao Chang, et al.. (2020). Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene. 39(47). 7034–7050. 9 indexed citations
9.
Doheny, Daniel, Sherona Sirkisoon, Tadas Rimkus, et al.. (2020). Abstract 5025: Antifungal ketoconazole inhibits tumor-specific transcription factor tGLI1 leading to suppression of breast cancer stem cells and brain metastasis. Cancer Research. 80(16_Supplement). 5025–5025. 1 indexed citations
10.
Sirkisoon, Sherona, Richard L. Carpenter, Tadas Rimkus, et al.. (2019). TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment. Oncogene. 39(1). 64–78. 72 indexed citations
11.
Sirkisoon, Sherona, Richard L. Carpenter, Tadas Rimkus, et al.. (2018). Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene. 37(19). 2502–2514. 79 indexed citations
12.
Rimkus, Tadas, Richard L. Carpenter, Sherona Sirkisoon, et al.. (2018). Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Research. 78(10). 2589–2600. 32 indexed citations
13.
Reddick, Jason J., et al.. (2017). First Biochemical Characterization of a Methylcitric Acid Cycle from Bacillus subtilis Strain 168. Biochemistry. 56(42). 5698–5711. 11 indexed citations
14.
Carpenter, Richard L., Sherona Sirkisoon, Dongqin Zhu, et al.. (2017). Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget. 8(43). 73947–73963. 35 indexed citations
15.
Rimkus, Tadas, et al.. (2017). Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.. PubMed. 23(128). 325–330. 24 indexed citations
16.
Carpenter, Richard L., Ivy Paw, Hu Zhu, et al.. (2015). The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Oncotarget. 6(26). 22653–22665. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos R. Gil Del Alcazar Breakdown of academic impact, for papers by Craig Harlos Breakdown of academic impact, for papers by Svetlana Miklikova Breakdown of academic impact, for papers by Patrick Grierson Breakdown of academic impact, for papers by JulieAnn Rader Breakdown of academic impact, for papers by Austin Y. Shull Breakdown of academic impact, for papers by Feda H. Hamdan Breakdown of academic impact, for papers by Cheri A. Pasch Breakdown of academic impact, for papers by Paula Kroon Breakdown of academic impact, for papers by Ziao Lin
Rankless by CCL
2026